aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
BIOS Health: Pioneering neural interfaces for medical advancements in the UK.
Bios Health, originally known as Cambridge Bio-Augmentation Systems (CBAS), was founded with the mission to revolutionize medical treatments through advanced neural interfaces. The company focuses on decoding nerve data to develop precision medicine solutions. Their core products and services include AI-driven neural interfaces designed to understand and manipulate nerve signals for various medical applications. Bios Health aims to lead the market in neural treatments, leveraging cutting-edge technology to address complex neurological disorders.
Notable figures affiliated with Bios Health include experts in neuroscience, AI, and medical technology, although specific names are not provided. The company has attracted significant attention and investment from leading venture capital firms interested in healthcare innovation. Key achievements include pioneering advancements in neural interface technology and contributing to the emerging field of precision medicine. Bios Health's impact is profound, as it opens new possibilities for treating neurological conditions and enhancing the quality of life for patients worldwide.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private Equity
Main Product(s)
Neural Interfaces
Technology
AI, Machine Learning
Tags
Biotech, Healthtech
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Europe
When was Bios Health founded?
Bios Health was founded in 2015.
Where is Bios Health’s headquarters located?
Bios Health’s headquarters is located in Cambridge, CAM, GB.
When was Bios Health’s last funding round?
Bios Health’s most recent funding round was for $20M (USD) in June 2023.
How many employees does Bios Health have?
Bios Health has 40 employees as of Feb 24, 2024.
How much has Bios Health raised to-date?
As of July 05, 2023, Bios Health has raised a total of $46.5M (USD) since Jun 22, 2023.
Add Comparison
Total Raised to Date
$46.5M
USD
Last Update Jun 22, 2023
Last Deal Details
$20M
USD
Jun 22, 2023
Series A
Total Employees Over Time
40
As of Feb 2024
Bios Health Address
Cambridge,
Cambridgeshire
CB2 1NN
United Kingdom
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts